Cancer News

Zanubrutinib Outperforms Ibrutinib in PFS for RR CLL/SLL: ALPINE Trial

Apr 3, 2023 12:43:42 PM / by Mehrdad Mobasher, MD, MPH posted in ASH, Zanubrutinib, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Mehrdad Mobasher

0 Comments

Zanubrutinib Outperforms Ibrutinib in Treating Relapsed/Refractory CLL/SLL Dr. Mobasher - Synopsis below extracted from the video transcript.

 

Read More

Subscribe to Email Updates

Recent Posts